Citra Buana Prasida Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Citra Buana Prasida Tbk. trades at Rp282 (market cap 385.18B, 10.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Citra Buana Prasida Tbk. is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (71K versus 10.2K). Which is the better fit depends on your goals.
| CBPE | OBAT | |
|---|---|---|
Market Cap | 385.18B | 167.37B |
Volume | 10.2K | 71K |
Lot | 102 | 710 |
Turnover | 2.9M | 17.51M |
Average Price | 283.88 | 246.63 |
Value | 2.9M | 17.51M |
Indicative Equilibrium Price | — | 246 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Buana Prasida Tbk Entity which was originally named PT Prasetia Sejati was established on August 24, 2000 based on the Deed of Establishment No. 18, drawn up in the presence of Ninik Sukadarwati, SH., Notary of the Bekasi Regency Level II, in Tambun. The Entity started its commercial business in 2005.
Read more on CBPE →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →